Neurotoxicity of MDMA: Main effects and mechanisms.
Costa G, Gołembiowska K.
Exp Neurol. 2022 Jan;347:113894. doi: 10.1016/j.expneurol.2021.113894. Epub 2021 Oct 13.
Hallucinogen Use Disorders.
Hardaway R, Schweitzer J, Suzuki J.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):489-96. doi: 10.1016/j.chc.2016.03.006. Epub 2016 Apr 18.
[Hallucinogenic mushrooms].
Reingardiene D, Vilcinskaite J, Lazauskas R.
Medicina (Kaunas). 2005;41(12):1067-70.
[Hallucinogen-induced psychological disorders].
Hermle L, Kovar KA, Hewer W, Ruchsow M.
Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191.
Is LSD toxic?
Nichols DE, Grob CS.
Forensic Sci Int. 2018 Mar;284:141-145. doi: 10.1016/j.forsciint.2018.01.006. Epub 2018 Feb 2.
Psychotomimetic compensation versus sensitization.
Brouwer A, Carhart-Harris RL, Raison CL.
Pharmacol Res Perspect. 2024 Aug;12(4):e1217. doi: 10.1002/prp2.1217.
N,N-Dimethyltryptamine: DMT-induced psychosis.
Barbic D, Fernandes J, Eberdt C, Chakraborty A.
Am J Emerg Med. 2020 Sep;38(9):1961.e1-1961.e2. doi: 10.1016/j.ajem.2020.04.090. Epub 2020 May 3.
Mushroom poisoning.
[No authors listed]
Med Lett Drugs Ther. 1984 Jul 20;26(666):67-9.
Psychosis and synthetic cannabinoids.
Deng H, Verrico CD, Kosten TR, Nielsen DA.
Psychiatry Res. 2018 Oct;268:400-412. doi: 10.1016/j.psychres.2018.08.012. Epub 2018 Aug 10.
Pheniramine as an hallucinogen.
Jones IH, Stevenson J, Jordan A, Connell HM, Hetherington HD, Gibney GN.
Med J Aust. 1973 Feb 24;1(8):382-6. doi: 10.5694/j.1326-5377.1973.tb118061.x.
